David Lally, MD: Perspective on ANX007 for Geographic Atroph

At AAO 2023, David Lally, MD describes results from the phase 2 ARCHER study and the potential benefit of intravitreal ANX007 for patients with GA.

Related Keywords

California , United States , San Francisco , American , David Lally , American Academy Of Ophthalmology , Annual American Academy , Retina Research Institute , New England Retina Consultants ,